Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2.

Source:http://linkedlifedata.com/resource/pubmed/id/2386933

Cancer Res. 1990 Sep 1 50 17 5234-9

Download in:

View as

Triples

General Info

PMID
2386933